Key result
Sarcomeric gene mutations drive HCM by altering calcium handling and increasing energy expenditure.
Why the study?
With technological advancements in sequencing techniques and increasing availability of genetic testing in cardiology, foundational knowledge on HCM pathophysiology, molecular genetics, and result interpretation is essential for personalized medicine.
This review provides a comprehensive overview of the molecular genetics of hypertrophic cardiomyopathy, emphasizing the importance of genetic testing and variant interpretation in personalized cardiovascular medicine.
May guide genetic testing in HCM evaluation; confirms sarcomeric mutations predominate while leaving therapeutic translation open.
Hypertrophic cardiomyopathy (HCM) is one of the most common types of inherited cardiomyopathy with a wide range of clinical manifestations ranging from subtle myocardial hypertrophy to debilitating heart failure, cardiac arrhythmias, and sudden cardiac death. We reviewed the literature on the latest knowledge regarding the pathophysiology and molecular genetic basis of HCM. This will include laboratory studies on animal models and human pluripotent stem-cell derived cardiomyocytes and the theory of proximal mechanisms involving calcium handling and energy expenditure underlying HCM. The current review will also illustrate the pathogenicity of various associated genetic variants, genotype-phenotype correlation and the optimal approach to genetic testing in HCM relevant to current practice. With technological advancements in sequencing technique and increasing availability of genetic testing in cardiology practice, a grasp of foundational knowledge on inherited cardiovascular conditions such as HCM, various sequencing techniques, interpretation of genetic testing results as well as counselling techniques become imminent to modern practice of personalized medicine.
No takes yet. Share an insight, caveat, or question.
Derek Pok Him Lee (2023) conducted a review in Hypertrophic cardiomyopathy. Hypertrophic cardiomyopathy is predominantly caused by mutations in sarcomeric genes such as MYH7 and MYBPC3, leading to altered calcium handling and increased energy expenditure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: